C1AG
ABBV icon

Client 1st Advisory Group’s AbbVie ABBV Stock Holding History

Client 1st Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$318K Sell
1,264
-6
-0.5% -$1.29K 0.08% 107
2026
Q1 		$276K Buy
1,270
+5
+0.4% +$1.11K 0.08% 109
2025
Q4 		$289K Buy
1,265
+289
+30% +$65.8K 0.09% 114
2025
Q3 		$226K Buy
+976
New +$199K 0.07% 121
2025
Q2 		– Sell
-964
Closed -$202K – 133
2025
Q1 		$202K Buy
+964
New +$187K 0.08% 128

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Client 1st Advisory Group's ABBV Position: Q2 2026 in Review

Client 1st Advisory Group reduced its AbbVie (ABBV) stake by 0.47% in Q2 2026, selling an estimated $1.29K and leaving 1,264 shares worth $318K. The position accounts for 0.08% of the portfolio, ranked #107.

Client 1st Advisory Group first reported a position in ABBV in Q1 2025 and has held it in 5 quarters since. 926 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Client 1st Advisory Group held 1,264 shares of AbbVie worth $318K as of Q2 2026.
  • Client 1st Advisory Group sold 6 AbbVie shares in Q2 2026, an estimated $1.29K.
  • AbbVie made up 0.08% of Client 1st Advisory Group's portfolio in Q2 2026, its #107 holding.
  • Client 1st Advisory Group first reported a position in AbbVie in Q1 2025 and has held it in 5 quarters since.
  • 926 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Client 1st Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.